AMST
A fresh customer win, and the market noticed
Amesite didn’t exactly sneak into Wednesday’s tape — the stock jumped after the company said it landed its largest enterprise customer yet for its AI-native NurseMagic documentation platform. The deal covers an approximately 2,700-patient census, which is a very specific way of saying: this isn’t a toy pilot, it’s a real deployment with real operational stakes.
Why investors care
The new client is using NurseMagic across its workforce to help cut down on the kind of paperwork that can eat up a caregiver’s day like a black hole with a clipboard. Amesite says the rollout will help streamline clinical workflows and connect EMR and EVV systems, which is the kind of back-office plumbing investors love when it turns into recurring software revenue.
The earnings piece was nice, too
The company also reported third-quarter results showing a narrower loss of 15 cents per share, versus a 16-cent loss a year ago. Revenue rose to $83,332 from $30,690 in the same quarter last year — still tiny in absolute terms, but at least it’s moving in the right direction.
Big picture: small company, big ambitions
Amesite is trying to muscle into the massive non-acute care market, and it’s doing the classic startup thing: promise big, sell into a painful workflow, and hope the first few wins turn into a flywheel. With the stock already ripping as much as 147% since Monday, the bar is now simple and brutal: prove this customer is the first of many, not a one-hit wonder.